Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|February 9, 2007
P2X(7) receptor activation causes phosphatidylserine exposure in human erythrocytesRonald Sluyter, Anne N Shemon, James S WileyImmunology and Cell Biology|November 30, 2006
Rottlerin inhibits P2X(7) receptor-stimulated phospholipase D activity in chronic lymphocytic leukaemia B-lymphocytesAnne N Shemon, Ronald Sluyter, James S WileyJournal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytesRonald Sluyter, Anne N Shemon, James S WileyThe Journal of Biological Chemistry|August 12, 2004
Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X7 receptorRonald Sluyter, Anne N Shemon, Julian A Barden, et al.IUBMB Life|August 19, 2006
Phospholipid signalling through phospholipase D and phosphatidic acidRosanna Cazzolli, Anne N Shemon, Michelle Q Fang, et al.British Journal of Pharmacology|June 24, 2004
Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptorAnne N Shemon, Ronald Sluyter, Arthur D Conigrave, et al.Biochemical and Biophysical Research Communications|November 15, 2007
Inhibition of the human P2X7 receptor by a novel protein tyrosine kinase antagonistAnne N Shemon, Ronald Sluyter, Leanne Stokes, et al.Plos One|May 14, 2010
Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligandsAnne N Shemon, Gary L Heil, Alexey E Granovsky, et al.Lancet (London, England)|April 12, 2002
A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular studyJames S Wiley, L Phuong Dao-Ung, Ben J Gu, et al.Plos One|June 25, 2009
Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migrationAnne N Shemon, Eva M Eves, Matthew C Clark, et al.Pageof 2